Modification of the ocular immune response. I. Use of antilymphocytic serum to prevent immune rejection of penetrating corneal homografts
- PMID: 4887870
Item in Clipboard
Modification of the ocular immune response. I. Use of antilymphocytic serum to prevent immune rejection of penetrating corneal homografts
Invest Ophthalmol.
1969 Apr.
No abstract available
Similar articles
-
The ocular immune response. II. Immune rejection of penetrating corneal homografts. Early versus late treatment with antilymphocyte serum.Transplantation. 1969 Aug;8(2):147-51. Transplantation. 1969. PMID: 4896328 No abstract available.
-
Suppression of the corneal homograft reaction by antilymphocyte serum.Arch Ophthalmol. 1969 Apr;81(4):571-6. doi: 10.1001/archopht.1969.00990010573020. Arch Ophthalmol. 1969. PMID: 4888031 No abstract available.
-
Graft rejection.Arch Intern Med. 1969 Jun;123(6):713-8. Arch Intern Med. 1969. PMID: 4890441 Review. No abstract available.
-
[Antilymphocytic serum].Policlinico Prat. 1968 Jul 1;75(27):883-6. Policlinico Prat. 1968. PMID: 4174248 Italian. No abstract available.
-
Mode of action of antilymphocyte serum.Surg Gynecol Obstet. 1969 Oct;129(4):717-22. Surg Gynecol Obstet. 1969. PMID: 4898242 Review. No abstract available.
Cited by
-
Subconjunctival injection of antilymphocyte serum during corneal hypersensitivity to heterologous alubmin.Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1975 Aug 4;196(1):79-83. doi: 10.1007/BF00410029. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1975. PMID: 1080640
-
Corneal allograft rejection.Br J Ophthalmol. 1994 Aug;78(8):649-52. doi: 10.1136/bjo.78.8.649. Br J Ophthalmol. 1994. PMID: 7918294 Free PMC article. Review. No abstract available.